Thrombotic Microangiopathies
"Thrombotic Microangiopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.
| Descriptor ID |
D057049
|
| MeSH Number(s) |
C15.378.140.855.925
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thrombotic Microangiopathies".
Below are MeSH descriptors whose meaning is more specific than "Thrombotic Microangiopathies".
This graph shows the total number of publications written about "Thrombotic Microangiopathies" by people in this website by year, and whether "Thrombotic Microangiopathies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 5 | 1 | 6 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2024 | 2 | 0 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thrombotic Microangiopathies" by people in Profiles.
-
Thrombomodulin protects against acute vascular and multiorgan injury in sickle cell disease. JCI Insight. 2026 01 23; 11(2).
-
The outcome of thrombotic microangiopathy in kidney transplant recipients. BMC Nephrol. 2024 11 28; 25(1):433.
-
Thrombotic Microangiopathies and the Kidney. Adv Kidney Dis Health. 2024 05; 31(3):255-264.
-
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy. Bone Marrow Transplant. 2022 09; 57(9):1445-1447.
-
Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers. Adv Chronic Kidney Dis. 2022 03; 29(2):149-160.e1.
-
Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults. Leuk Lymphoma. 2022 02; 63(2):473-477.
-
Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020 12 08; 4(23):6051-6063.
-
MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab. Clin Exp Immunol. 2021 01; 203(1):96-104.
-
Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients. Br J Haematol. 2020 08; 190(3):450-457.
-
Complement and Renal Thrombotic Microangiopathy Associated With Hypertension and Scleroderma. Adv Chronic Kidney Dis. 2020 03; 27(2):149-154.